Kursinformation
Aktuelle News
News Funktionen
Weitere Funktionen
25 März 2019
Glycotope GmbH
Glycotope Expands Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies to Include Marketed Anti-Tumor Antibodies (news with additional features)
30 Juli 2018
Glycotope GmbH
Glycotope GmbH: Daiichi Sankyo Enters Worldwide Licensing Agreement with Glycotope for Gatipotuzumab Antibody Drug Conjugate (news with additional features)
18 Juli 2018
Glycotope GmbH
DCprime and Glycotope announce licensing agreement and collaboration (news with additional features)
22 Dezember 2017
Glycotope GmbH
Glycotope Initiates Phase Ib Trial of Combination of Proprietary Anti-Tumor Antibodies (news with additional features)
21 September 2017
Glycotope GmbH
Glycotope lizensiert GlycoExpress Zelllinie an Airway Therapeutics
29 April 2016
Glycotope GmbH
Glycotope GmbH: Glycotope ernennt Dr. Alfredo Zurlo zum Chief Medical Officer